Lipid and apolipoprotein ratios: Association with coronary artery disease and effects of rosuvastatin compared with atorvastatin, pravastatin, and simvastatin - Discussion

Lipid and apolipoprotein ratios: Association with coronary artery disease and effects of rosuvastatin compared with atorvastatin, pravastatin, and simvastatin - Discussion

Bibliographic Details
Main Authors:	Stein, E, Shepherd, J, Barter, P, Hobbs, R
Format:	Journal article
Published:	2003

Similar Items

Guidelines for lowering lipids to reduce coronary artery disease risk: A comparison of rosuvastatin with atorvastatin, pravastatin, and simvastatin for achieving lipid-lowering goals - Discussion
by: Davidson, M, et al.
Published: (2003)

Comparison of Cost-Effectiveness, Safety, and Efficacy of Rosuvastatin Versus Atorvastatin, Pravastatin, and Simvastatin in Dyslipidemic Diabetic Patients With or Without Metabolic Syndrome
by: Abdulbari Bener, et al.
Published: (2014-07-01)

Antibacterial activity of statins: a comparative study of Atorvastatin, Simvastatin, and Rosuvastatin
by: Masadeh Majed, et al.
Published: (2012-05-01)

Rosuvastatin is Superior Compared to Simvastatin and Atorvastatin to Induce Endothelial Progenitor Cells Migration
by: Yudi Her Oktaviono, et al.
Published: (2019-05-01)

A comparison of the effectiveness of rosuvastatin, atorvastatin and simvastatin in achieving target lipid levels (according to the PROFILE-I registry)
by: Oleg V Gaisenok
Published: (2017-12-01)

Relationship between genetic polymorphism of drug transporters and the efficacy of Rosuvastatin, atorvastatin and simvastatin in patients with hyperlipidemia
by: Andrey Sivkov, et al.
Published: (2021-11-01)

Effect of Pravastatin and Simvastatin on the Reduction of Cytochrome C
by: Krisztián Csomó, et al.
Published: (2022-07-01)

Cost-effectiveness of rosuvastatin in comparison with generic atorvastatin and simvastatin in a Swedish population at high risk of cardiovascular events
by: Gandhi SK, et al.
Published: (2012-01-01)

Apolipoprotein E gene polymorphisms: a relationship with the risk of coronary artery disease and the effectiveness of lipid-lowering therapy with rosuvastatin
by: M. I. Churilin, et al.
Published: (2020-03-01)

Combination treatment of rosuvastatin or atorvastatin, with regular exercise improves arterial wall stiffness in patients with coronary artery disease.
by: Kensuke Toyama, et al.
Published: (2012-01-01)

Simvastatin-induced nocturnal leg pain disappears with pravastatin substitution
by: Stojaković Nataša, et al.
Published: (2013-01-01)

Correction: Combination Treatment of Rosuvastatin or Atorvastatin, with Regular Exercise Improves Arterial Wall Stiffness in Patients with Coronary Artery Disease
Published: (2013-01-01)

Correction: Combination Treatment of Rosuvastatin or Atorvastatin, with Regular Exercise Improves Arterial Wall Stiffness in Patients with Coronary Artery Disease.
by: Kensuke Toyama, et al.
Published: (2013-01-01)

Comparative effects of pravastatin and rosuvastatin on carbohydrate metabolism in an experimental diabetic rat model
by: Kaya Hacer Kayhan, et al.
Published: (2024-03-01)

A comparative study of atorvastatin and rosuvastatin on lipid lowering efficacy in hyperlipidemic patients
by: Samia Haque Tonu, et al.
Published: (2018-03-01)

Changes in LDL-C levels and goal attainment associated with addition of ezetimibe to simvastatin, atorvastatin, or rosuvastatin compared with titrating statin monotherapy
by: Foody JM, et al.
Published: (2013-11-01)

Efficacy of Combination Therapy of Rosuvastatin and Ezetimibe vs Rosuvastatin Monotherapy on Lipid Profile of Patients with Coronary Artery Disease
by: Sandeep Joshi, et al.
Published: (2017-12-01)

Effects of Rosuvastatin on Apolipoprotein J in Balloon-Injured Carotid Artery in Rats
by: Ning Yang, et al.
Published: (2018-09-01)

COMPARISON OF LIPID LOWERING EFFECTS OF ROSUVASTATIN AND ATORVASTATIN IN TYPE 2 DIABETIC PATIENTS WITH PRIMARY HYPERLIPIDEMIA
by: Safina Shabbir, et al.
Published: (2020-12-01)

Effects of atorvastatin and rosuvastatin on dysfunctional coronary circulation in patients with ST-segment elevation myocardial infarction
by: Langping Zhou, et al.
Published: (2023-06-01)

Differential effects of pravastatin and simvastatin on the growth of tumor cells from different organ sites.
by: David G Menter, et al.
Published: (2011-01-01)

Pravastatin But Not Simvastatin Improves Survival and Neurofunctional Outcome After Cardiac Arrest and Cardiopulmonary Resuscitation
by: Stefan Bergt, MD, et al.
Published: (2017-04-01)

Pravastatin Inhibits Arrhythmias Induced by Coronary Artery Ischemia in Anesthetized Rats
by: Jianguang Chen, et al.
Published: (2007-01-01)

LIPID-LOWERING EFFICACY OF 20 MG SIMVASTATIN VERSUS 5 MG ROSUVASTATIN IN PATIENTS OF TYPE 2 DIABETES
by: Hafiz Muhammad Yasir Rehman, et al.
Published: (2020-08-01)

Atorvastatin and simvastatin in clinical management of high-risk patients
by: S. A. Shalnova, et al.
Published: (2009-02-01)

Chronic pravastatin but not atorvastatin treatment impairs cognitive function in two rodent models of learning and memory.
by: Sarah A Stuart, et al.
Published: (2013-01-01)

Comparison of the Efficacy of Atorvastatin and Rosuvastatin in Preventing Atrial Fibrillation after Coronary Artery Bypass Grafting: A Double-blind Randomized Comparative Trial
by: Zahra Samadifar, et al.
Published: (2023-04-01)

Comparison of the effects of maximal dose atorvastatin and rosuvastatin therapy on cholesterol synthesis and absorption markers*[S]
by: Thomas M. van Himbergen, et al.
Published: (2009-04-01)

Comparison of rosuvastatin and atorvastatin for lipid lowering in patients with type 2 diabetes mellitus: results from the URANUS study
by: Berne Christian, et al.
Published: (2005-06-01)

Lipid-Associated GWAS Loci Predict Antiatherogenic Effects of Rosuvastatin in Patients with Coronary Artery Disease
by: Stanislav Kononov, et al.
Published: (2023-06-01)

Differential effects of simvastatin and pravastatin on expression of Alzheimer's disease-related genes in human astrocytes and neuronal cells
by: Weijiang Dong, et al.
Published: (2009-10-01)

Effects of Atorvastatin and Pravastatin on Signal Transduction Related to Glucose Uptake in 3T3L1 Adipocytes
by: Akira Takaguri, et al.
Published: (2008-01-01)

Comparison of the efficacy and safety of rosuvastatin 10 mg and atorvastatin 20 mg in high-risk patients with hypercholesterolemia – Prospective study to evaluate the Use of Low doses of the Statins Atorvastatin and Rosuvastatin (PULSAR)
by: García Hugo, et al.
Published: (2006-12-01)

Comparison between rosuvastatin and atorvastatin for the prevention of contrast-induced nephropathy in patients with STEMI undergoing primary percutaneous coronary intervention
by: Ata Firouzi, et al.
Published: (2018-09-01)

THE INFLUENCE OF ATORVASTATIN AND ROSUVASTATIN IN ATHEROSCLEROSIS ON THE PARAMETERS OF CELLULAR IMMUNITY AND IN VITRO LEUCOCYTE ACTIVATION
by: A. Yu. Filatova, et al.
Published: (2018-09-01)

Optimization of RPLC Conditions for Quantitative Analysis of Atorvastatin and Rosuvastatin in Pharmaceutical Dosage Form
by: Zehra ÜSTÜN, et al.
Published: (2016-05-01)

Rosuvastatin and Atorvastatin: Comparative Effects on Glucose Metabolism in Non-Diabetic Patients with Dyslipidaemia
by: Ahmed Abbas, et al.
Published: (2012-01-01)

Rosuvastatin and Atorvastatin: Comparative Effects on Glucose Metabolism in Non-Diabetic Patients with Dyslipidaemia
by: Sudarshan Ramachandran, et al.
Published: (2012-02-01)

Comparison between Atorvastatin and Rosuvastatin in Renal Function Decline among Patients with Diabetes
by: Eugene Han, et al.
Published: (2017-06-01)

Short Term Comparison Between Safety and Efficacy of Rosuvastatin 40 mg and Atorvastatin 80 mg in Patients with Acute Coronary Syndrome
by: Sh. A. Mostafa, et al.
Published: (2018-11-01)